Literature DB >> 24410859

Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.

J Segelman1, O Akre, U O Gustafsson, M Bottai, A Martling.   

Abstract

AIM: The purpose of the study was to develop a tool for predicting the individual risk of metachronous peritoneal carcinomatosis after surgery for non-metastatic colorectal cancer.
METHOD: Independent predictors for metachronous colorectal carcinomatosis have previously been identified using a population-based database. Predictive models for colon and rectal cancer were developed from these data. The predictive models were based on multivariable Cox proportional hazard regression and were internally validated with bootstrapping. Performance was assessed by the concordance index and calibration plots.
RESULTS: In all, 8044 patients who underwent abdominal resection of colorectal cancer Stage I-III were included. The colon and rectal cancer risk score models predicted metachronous peritoneal carcinomatosis with a concordance index of 80% and 78%, respectively. Factors in the models included age, pathological pT stage, pN stage, number of examined lymph nodes (0-11, 12+), type of surgery (emergency/elective), completeness of cancer resection (R0/R1/R2), adjuvant chemotherapy (yes/no), preoperative radiotherapy and tumour location.
CONCLUSION: The proposed predictive models showed high internal validity and enabled individualized prediction of peritoneal recurrence of colorectal cancer. The models may help in the planning of treatment and follow-up of patients. However, external validation is warranted to assess generalizability of the predicted absolute risks. Colorectal Disease
© 2014 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Colorectal cancer; individual risk; peritoneal carcinomatosis

Mesh:

Year:  2014        PMID: 24410859     DOI: 10.1111/codi.12552

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  18 in total

Review 1.  Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research.

Authors:  Checca Bakkers; Geert A A M Simkens; Ignace H J T De Hingh
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 2.  Current treatment options for colon cancer peritoneal carcinomatosis.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.

Authors:  Nikolaos Vassos; Pompiliu Piso
Journal:  Curr Treat Options Oncol       Date:  2018-09-01

Review 4.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

5.  Nomograms for colorectal cancer: A systematic review.

Authors:  Kazushige Kawai; Eiji Sunami; Hironori Yamaguchi; Soichiro Ishihara; Shinsuke Kazama; Hiroaki Nozawa; Keisuke Hata; Tomomichi Kiyomatsu; Junichiro Tanaka; Toshiaki Tanaka; Takeshi Nishikawa; Joji Kitayama; Toshiaki Watanabe
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 6.  The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases.

Authors:  Lana Bijelic; Isabel Ramos; Diane Goeré
Journal:  Ann Surg Oncol       Date:  2021-05-09       Impact factor: 5.344

7.  Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials.

Authors:  Michitaka Honda; Koji Oba; Takashi Akiyoshi; Hiromichi Maeda; Kosuke Kashiwabara; Mitsuro Kanda; Shuhei Mayanagi; Toru Aoyama; Chikuma Hamada; Sotaro Sadahiro; Yosuke Fukunaga; Masashi Ueno; Junichi Sakamoto; Shigetoyo Saji; Takaki Yoshikawa
Journal:  Oncotarget       Date:  2017-10-12

8.  Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?

Authors:  Delia Cortes-Guiral; Dominique Elias; Pedro Antonio Cascales-Campos; Alfredo Badía Yébenes; Ismael Guijo Castellano; Ana Isabel León Carbonero; José Ignacio Martín Valadés; Jesus Garcia-Foncillas; Damian Garcia-Olmo
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

9.  Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies.

Authors:  Wei Xu; Yazhou He; Yuming Wang; Xue Li; Jane Young; John P A Ioannidis; Malcolm G Dunlop; Evropi Theodoratou
Journal:  BMC Med       Date:  2020-06-26       Impact factor: 8.775

Review 10.  Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.

Authors:  Geert A Simkens; Koen P Rovers; Simon W Nienhuijs; Ignace H de Hingh
Journal:  Cancer Manag Res       Date:  2017-06-30       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.